ESSA Pharmaceuticals   Report issue

For profit Phase 2
Founded: Vancouver BC Canada (2009)

Organization Overview

First Clinical Trial
2015
NCT02606123
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ESSA Pharmaceuticals | ESSA Pharmaceuticals Corp.